Prostate-specific membrane androgen PET/CT can help clinicians intensify or de-escalate care for men with prostate cancer who have biochemical recurrence following radical prostatectomy.A retrospective evaluation of patients treated at UCLA showed staging from prostate-specific membrane androgen (PSMA) PET/CT before salvage radiotherapy had a significant association with PFS, and certain therapies benefited patients with specific staging […]
Source